Beerens, D., Franch-Arroyo, S., Sullivan, T.J., Goosmann, C., Brinkmann, V., Charpentier, E. (2021) Survival strategies of Streptococcus pyogenes in response to phage infection. Viruses, 13(4), 612.


Galvez, E. J. C., Iljazovic, A., Amend, L., Lesker, T. R., Renault, T., Thiemann, S., Hao, L., Roy, U., Gronow, A., Charpentier, E., & Strowig, T. (2020). Distinct Polysaccharide Utilization Determines Interspecies Competition between Intestinal Prevotella spp. Cell Host & Microbe, 28(6), 838-852.e6.
Righetti, F., Materne, S. L., Boss, J., Eichner, H., Charpentier, E., & Loh, E. (2020). Characterization of a transcriptional TPP riboswitch in the human pathogen Neisseria meningitidis. RNA Biology, 17(5), 718–730.
Bratovic, M., Fonfara, I., Chylinski, K., Galvez, E. J. C., Sullivan, T. J., Boerno, S., Timmermann, B., Boettcher, M., & Charpentier, E. (2020). Bridge helix arginines play a critical role in Cas9 sensitivity to mismatches. Nature Chemical Biology, 16(5), 587-595.
Broglia, L., Lecrivain, A.-L., Renault, T. T., Hahnke, K., Ahmed-Begrich, R., Le Rhun, A., & Charpentier, E. (2020). An RNA-seq based comparative approach reveals the transcriptome-wide interplay between 3 ’-to-5 ’ exoRNases and RNase Y. Nature Communications, 11(1), 1587.
Makarova, K. S., Wolf, Y., Iranzo, J., Shmakov, S. A., Alkhnbashi, O. S., Brouns, S. J. J., Charpentier, E., Cheng, D., Haft, D. H., Horvath, P., Moineau, S., Mojica, F. J. M., Scott, D., Shah, S. A., Siksnys, V., Terns, M. P., Venclovas, C., White, M. F., Yakunin, A. F., … Koonin, E. (2020). Evolutionary classification of CRISPR-Cas systems: A burst of class 2 and derived variants. Nature Reviews Microbiology, 18(2), 67–83.


Ratner, H. K., Escalera-Maurer, A., Le Rhun, A., Jaggavarapu, S., Wozniak, J. E., Crispell, E. K., Charpentier, E., & Weiss, D. S. (2019). Catalytically Active Cas9 Mediates Transcriptional Interference to Facilitate Bacterial Virulence. Molecular Cell, 75(3), 498-510.
Le Rhun, A., Escalera-Maurer, A., Bratovic, M., & Charpentier, E. (2019). CRISPR-Cas in Streptococcus pyogenes. RNA Biology, 16(4), 380–389.
Charpentier, E., Elsholz, A., & Marchfelder, A. (2019). CRISPR-Cas: More than ten years and still full of mysteries. RNA Biology, 16(4), 377–379.
Davies, K., & Charpentier, E. (2019). Finding Her Niche: An Interview with Emmanuelle Charpentier. CRISPR Journal, 2(1), 17–22.

Lander, E., Baylis, F., Zhang, F., Charpentier, E., & Berg, P. (2019). Adopt a moratorium on heritable genome editing. Nature, 567(7747), 165–168.


Lecrivain, A.-L., Le Rhun, A., Renault, T. T., Ahmed-Begrich, R., Hahnke, K., & Charpentier, E. ( 2018). In vivo 3 ’-to-5 ’ exoribonuclease targetomes of Streptococcus pyogenes. Proceedings of the National Academy of Sciences of the United States of America, 115(46), 11814–11819.
Broglia, L., Materne, S., Lecrivain, A.-L., Hahnke, K., Le Rhun, A., & Charpentier, E. (2018). RNase Y-mediated regulation of the streptococcal pyrogenic exotoxin B. RNA Biology, 15(10), 1336–1347.
Tsatsaronis, J. A., Franch-Arroyo, S., Resch, U., & Charpentier, E. (2018). Extracellular Vesicle RNA: A Universal Mediator of Microbial Communication? Trends in Microbiology, 26(5), 401–410.
Hille, F., Richter, H., Wong, S. P., Bratovic, M., Ressel, S., & Charpentier, E. (2018). The Biology of CRISPR-Cas: Backward and Forward. Cell, 172(6), 1239–1259.
Labuhn, M., Adams, F. F., Ng, M., Knoess, S., Schambach, A., Charpentier, E. M., Schwarzer, A., Mateo, J. L., Klusmann, J.-H., & Heckl, D. (2018). Refined sgRNA efficacy prediction improves large- and small-scale CRISPR-Cas9 applications. Nucleic Acids Research, 46(3), 1375–1385.
Charpentier, E. (2018). Spotlight on... Emmanuelle Charpentier. FEMS Microbiology Letters, 365(4), fnx271.

Prior to 2018

For publications prior to 2018, click here

Go to Editor View